Document is current
Any future updates will be listed below
-
Authors
Ferri Grazzi, Enrico
Becker, Tobias
Brandt, Stephanie
Duport, Gaetan
Garcia Diego, Daniel-Anibal
Lupi, Angelo
McKeown, William
Morgan, Debra
Camp, Charlotte
Hawes, Charles
Blenkiron, Tom https://orcid.org/0000-0002-5716-0748
O’Hara, Jamie
Burke, Tom
-
Funding
Funding for this research was provided by:
BioMarin Pharmaceutical
- License Information
-
More Information
Article History
Received: 30 April 2024
Accepted: 24 July 2024
First Online: 17 August 2024
Declarations
:
: Enrico Ferri Grazzi, Tom Blenkiron, Jamie O’Hara and Tom Burke are employees of HCD Economics Ltd., a consultancy which received research funding from BioMarin Europe; Charlotte Camp and Charles Hawes are employees and stockholders of BioMarin Pharmaceutical, Inc. Tobias Becker, Stephanie Brandt, Gaetan Duport, Daniel-Anibal Garcia Diego, Angelo Lupi, William McKeown and Debra Morgan have nothing to disclose.
: The CHESS II study was approved by the Research Ethics committee of the Faculty of Health and Social Care within the University of Chester (UK) and was conducted in accordance with regional and relevant guidelines. The study was conducted in collaboration with the UK Haemophilia Society and governed by a steering committee chaired by Mr Brian O’Mahony, Chief Executive of the Irish Haemophilia Society.
